Akero Therapeutics, Inc. (AKRO)
Dec 9, 2025 - AKRO was delisted (reason: acquired by NVO)
54.65
0.00 (0.00%)
Inactive · Last trade price on Dec 8, 2025
Akero Therapeutics Stock Forecast
Stock Price Forecast
The 11 analysts with 12-month price forecasts for Akero Therapeutics stock had an average target of $73.56, with a low estimate of $54 and a high estimate of $109.
Price Target: $73.56 (+34.60%)
Analyst Consensus: Buy
Price Target
Analyst Ratings
The average analyst rating for Akero Therapeutics stock from 11 stock analysts was "Buy". This means that analysts believed this stock was likely to outperform the market over the next twelve months.
Recommendation Trends
No data available
| Rating | Oct 2026 |
|---|---|
| Strong Buy | n/a |
| Buy | n/a |
| Hold | n/a |
| Sell | n/a |
| Strong Sell | n/a |
| Total | n/a |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-3.79
from -3.75
EPS Next Year
-4.40
from -3.79
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | n/a | n/a | ||||
| Avg | n/a | n/a | ||||
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | - | ||||
| Avg | - | - | ||||
| Low | - | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | -3.77 | -4.18 | ||||
| Avg | -3.79 | -4.40 | ||||
| Low | -3.86 | -4.90 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | - | ||||
| Avg | - | - | ||||
| Low | - | - |